Thomas Kledal

CEO at Synklino

Speaker

Thomas Kledal, PhD, MBA is CEO and Co-founder of Synklino A/S, a biotechnology company advancing innovative antiviral therapies toward clinical application in transplantation. He has led the company since its founding, securing significant venture funding, building multidisciplinary leadership teams, and driving strategic, regulatory, and scientific development of Synklino’s lead programs.

With more than 25 years of experience spanning biotechnology, virology, innovation management, and entrepreneurship, Dr. Kledal has held senior leadership positions in academia and industry, including Head of Section for Virology at the Technical University of Denmark (DTU), where he led a high-impact research organization of more than 50 employees. He has also founded and led biotech ventures focused on antiviral drug discovery and played a key role in strengthening life science innovation collaborations between academia and industry. Dr. Kledal earned his PhD from the University of Copenhagen and completed postdoctoral research at Stanford University in the Department of Microbiology and Immunology.